Fodmapeveryday iconFodmapeverydaySep 28, 2026 ~6 min source read

Dietary Yeast Beta-Glucan Changed Bone‑Marrow Immune Development and Strengthened Anti‑Tumor Responses in Mice

A mouse study found that a yeast-based dietary supplement altered early immune cell development in bone marrow and was associated with stronger anti-tumor immune activity across colorectal, skin, and breast cancer models. The work explores trained immunity via diet and examines effects tied to obesity.

Share this story

Send the public story page.

Useful takeaways from this story.

Dietary yeast beta‑glucan shifted early immune cell development in the bone marrow and was linked to stronger anti‑tumor responses in multiple mouse cancer models.

Researchers tested an oral (dietary) form of beta‑glucan rather than injectable immune‑training agents used in prior studies.

The study examined whether the supplement could reverse obesity‑related immune dysfunction and whether immune changes persisted after weight loss.

The useful part

Natural Supplement Research Reveals New Clues About the Immune System's Cancer-Fighting Response. The finding offers a new glimpse into how a dietary compound may reshape immune activity, especially in conditions where the body's defenses have been disrupted. The research focused on trained immunity, a process in which certain immune responses can be altered after exposure to specific signals.

How it works

  • Unlike earlier approaches that used injections of immune training compounds, the study examined whether a dietary form of yeast beta glucan could produce similar effects.
  • The work also explored obesity-related immune dysfunction, looking at whether the supplement could restore immune activity affected by obesity and whether those changes could continue after weight loss.
  • Researchers have investigated its relationship with immune pathways because it can interact with cells involved in the body's defenses.
  • The researchers found changes linked to stronger anti-tumor immune activity in mice.
  • The research examined cancer models involving colorectal, skin, and breast cancer, providing insight into how immune changes may influence responses across different tumor types.

What to take from it

Scientists studied yeast beta glucan because it may influence the body's immune response. A New Study Raises Questions About Cancer Risk New Research Raises Concerns About This Popular Drink and Its Possible Link to Colorectal Cancer Research Links This Common Mindless Habit to Higher Cancer Risk And You Might Be Doing It Daily Share this About FODMAP Everyday Low FODMAP Recipes Created Just For You! Beta glucan is a naturally occurring compound found in sources including yeast.

Example or evidence

  • Researchers have traditionally studied trained immunity through direct exposure to immune-stimulating substances.
  • Published reviews report that 64% to 81% of some cancer survivor groups use dietary supplements, although figures vary by population, supplement type, and study methods.
  • A product being researched does not automatically mean it has been established as a cancer treatment, and researchers must evaluate scientific findings in the context of the study design.
  • HayDmitriy via Depositphotos The next stage of research will determine whether findings seen in mice can translate into benefits for people.

Details worth keeping

In a study involving mice, researchers found that dietary yeast beta-glucan changed immune cell development in the bone marrow and was linked to stronger anti-tumor immune responses in models of colorectal, skin, and breast cancer. This study examined whether dietary intake could influence the same principle. The study investigated whether yeast beta-glucan could reverse aspects of obesity related immune dysfunction, including changes that remained after weight loss.

Related coverage

  • Scitechdaily: Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice.

More context around this story.

Loading more related stories...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app